| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.08 |